Other Events ·
At its 2026 Annual Meeting of Stockholders on June 23, 2026, CorMedix Inc. elected seven directors, approved executive…
CRMDCorMedix Inc.
At its 2026 Annual Meeting of Stockholders on June 23, 2026, CorMedix Inc. elected seven directors, approved executive compensation for 2025, and ratified the appointment of CBIZ CPAs P.C. as its independent auditor. Notably, stockholders failed to approve five separate proposals: the ratification of Certificate of Designation Amendments, technical changes to the amended and restated Charter, an amendment to allow class voting for preferred stock terms, the designation of exclusive forums for legal claims, and the updating of officer liability provisions under Delaware law. The company is a biopharmaceutical company that develops and commercializes products for the treatment of serious diseases.